CIBC Asset Management
CKPT

CIBC Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

CIBC Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,285
Closed -$23.1K – 1160
2024
Q1 		$23.1K Hold
11,285
– – ﹤0.01% 1121
2023
Q4 		$25.8K Hold
11,285
– – ﹤0.01% 1086
2023
Q3 		$19.2K Hold
11,285
– – ﹤0.01% 1038
2023
Q2 		$27.9K Hold
11,285
– – ﹤0.01% 1083
2023
Q1 		$25.4K Buy
+11,285
New +$56.6K ﹤0.01% 1054

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Asset Management's CKPT Position: Q2 2024 in Review

CIBC Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2024, closing a stake of 11,285 shares — an estimated $23.1K sold.

CIBC Asset Management first reported a position in CKPT in Q1 2023 and held it in 5 quarters. The position peaked at $27.9K in Q2 2023. 45 funds tracked by Wall St. Rank hold CKPT as of Q2 2024.

  • CIBC Asset Management reported no remaining Checkpoint Therapeutics position as of Q2 2024 after selling out during the quarter.
  • CIBC Asset Management sold 11,285 Checkpoint Therapeutics shares in Q2 2024, an estimated $23.1K.
  • CIBC Asset Management first reported a position in Checkpoint Therapeutics in Q1 2023 and held it in 5 quarters.
  • CIBC Asset Management's Checkpoint Therapeutics position peaked at $27.9K in Q2 2023.
  • 45 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2024.

Based on CIBC Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.